This topic contains a solution. Click here to go to the answer

Author Question: An appropriate outcome for institution of trihexyphenidyl (Artane) therapy in conjunction with high ... (Read 91 times)

DyllonKazuo

  • Hero Member
  • *****
  • Posts: 565
An appropriate outcome for institution of trihexyphenidyl (Artane) therapy in conjunction with high potency typical antipsychotic medication therapy is that client will:
 
  1. Demonstrate a brighter mood
  2. Be less sedated and drowsy
  3. Display fewer movement disorder symptoms
  4. Display decreased anticholinergic symptoms

Question 2

The nurse notes that a client who has been receiving paroxetine (Paxil) for symptoms of major depression and whose sensorium had been clear begins to behave as though somewhat confused and elated.
 
  The nurse also notes the presence of restlessness, muscle jerking, and diaphoresis. The nurse should assess these symptoms as probable:
  1. Neuroleptic malignant syndrome
  2. Anticholinergic blockade
  3. Serotonin syndrome
  4. Dystonia



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

ngr69

  • Sr. Member
  • ****
  • Posts: 318
Answer to Question 1

ANS: 3
Trihexyphenidyl is used to treat extrapyramidal symptoms such as pseudoparkinsonism. The oth-er options are not expected outcomes of administration of this medication.

Answer to Question 2

ANS: 3
These are symptoms of serotonin syndrome, a condition that requires medical intervention. The other options are not associated with SSRI therapy.





 

Did you know?

There are more bacteria in your mouth than there are people in the world.

Did you know?

Excessive alcohol use costs the country approximately $235 billion every year.

Did you know?

Everyone has one nostril that is larger than the other.

Did you know?

It is difficult to obtain enough calcium without consuming milk or other dairy foods.

Did you know?

The U.S. Preventive Services Task Force recommends that all women age 65 years of age or older should be screened with bone densitometry.

For a complete list of videos, visit our video library